# Aprepitant for Prevention of Postoperative Nausea and Vomiting in Elective Hysterectomy

> **NCT00888329** · PHASE4 · TERMINATED · sponsor: **Mayo Clinic** · enrollment: 256 (actual)

## Conditions studied

- Postoperative Nausea and Vomiting

## Interventions

- **DRUG:** Aprepitant
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00888329
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-07
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 256 (ACTUAL)
- **Why stopped:** Slow accrual.
- **Last updated:** 2012-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00888329

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00888329, "Aprepitant for Prevention of Postoperative Nausea and Vomiting in Elective Hysterectomy". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00888329. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*